SECONDARY CLASSIC PRIMARY HYPERPARATHYROIDISM TO A PARATHYROID ADENOMA
DOI:
https://doi.org/10.18041/2390-0512/biociencias.2.5004Keywords:
Symptomatic primary hyperparathyroidism, hypercalcemia, Parathyroid hormoneAbstract
Objective: To report a case of symptomatic primary hyperparathyroidism secondary to a parathyroid adenoma. Case: A 34-year-old woman with a 4-year history with multiple pathological fractures, weight loss, asthenia. The examinations revealed hypercalcemia, hypophosphimia and elevated PTH (968 pg / ml). He was hospitalized for severe joint pain management associated with multiple fragility fractures, with high levels of PTH (968 pg / mL) and gammagram and parathyroid prospect material 25mci 99m MIBI evidencing a pattern suggestive of lower left parathyroid adenoma. For which exeresis of the adenoma is performed. Discussion: Primary hyperparathyroidism (PHPT), a common endocrine disorder characterized by hypercalcemia and elevated or inadequately normal levels of PTH. Its diagnosis is based on a biochemical evaluation. One of the main causes is parathyroid adenoma or hyperplasia.
Downloads
References
2. Bandeira F, Cusano N, Silva BC, et al. Bone disease in primary hyperparathyroidism. Arq Bras Endocrinol Metabol 2014; 58: 553–61.
3. Yeh MW, Ituarte PH, Zhou HC, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab 2013; 98: 1122-9.
4. Bandeira F, Griz L, Caldas G, Bandeira C, Freese E. From mild to severe primary hyperparathyroidism: the Brazilian experience. Arq Bras Endocrinol Metabol 2006; 50: 657–63.
5. Eufrazino C, Veras A, Bandeira F. Epidemiology of primary hyperparathyroidism and its non-classical manifestations in the city of Recife, Brazil. Clin Med Insights Endocrinol Diabetes 2013; 6: 69–74.
6. Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 2002; 235:665-70.
7. Silva BC, Costa AG, Cusano NE, Kousteni S, Bilezikian JP. Catabolic and anabolic actions of parathyroid hormone on the skeleton. J Endocrinol Invest. 2011;34:801-10.
8. Albright, F., Aub, J. & Bauer, W. Hyperparathyroidism: common and polymorphic condition as illustrated by seventeen proven cases in one clinic. JAMA 102, 1276 (1934).
9. Khosla S, Melton LJ r, Wermers RA, Crowson CS, O'Fallon WM, Riggs Bl. Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res. 1999;14:1700-7.
10. Bilezikian J, Bandeira L, Khan A, Cusano N. Hyperparathyroidism. Lancet 2018; 391: 168–78.
11. Moghadam R, Amlelshahbaz A, Namiranian N, Sobhan-Ardekani M, Emami-Meybodi M, Dehghan A, et al. Diagnostic Performance of Ultrasonography and 99mTc-Sestamibi Scintigraphy for Parathyroid Adenoma in Primary Hyperparathyroidism; Systematic Review and Meta-AnalysisAsian Pac J Cancer Prev. 2017; 18(12): 3195–3200.
12. Insogna K, Primary Hyperparathyroidism. N Engl J Med 2018; 379:1050-9.
13. Norlén O, Wang K, Tay Y, Johnson W, Grodski S, Yeung M et al. No Need to Abandon Focused Parathyroidectomy. Annals of Surgery. 2015;261(5):991-996.
14. Joliat G, Guarnero V, Demartines N, Schweizer V, Matter M. Recurrent laryngeal nerve injury after thyroid and parathyroid surgery. Medicine. 2017;96(17):e6674.
Downloads
Published
Issue
Section
License
-
Reconocimiento — Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios<. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace.
-
NoComercial — No puede utilizar el material para una finalidad comercial.
-
CompartirIgual — Si remezcla, transforma o crea a partir del material, deberá difundir sus contribuciones bajo la misma licencia que el original.
- No hay restricciones adicionales — No puede aplicar términos legales o medidas tecnológicas que legalmente restrinjan realizar aquello que la licencia permite.
